Abstract
ANTITHYROID drugs are now well established in the medical treatment of hyperthyroidism. Used in long-term treatment they give a fairly high proportion of apparent permanent remissions, by most authors calculated to be from 50 to 75 per cent. With the newer drugs of this type, complications are relatively few. In fact Doniach (1) treated 120 patients with a new drug of the methimazole group (Neo-Mercazole) without any complications. The effect of roentgen irradiation in hyperthyroidism is widely disputed. Some authors are enthusiastic, whereas others find this treatment valueless. Pfahler (2) reports satisfactory results in 89 per cent of his patients; after only one month of such treatment he found some improvement, and after two months “very definite” improvement. Aagaard (3) records that 78 per cent of his patients had a remission. Rose (4), from his experience over a period of twenty years with 800 patients, states that satisfactory results were obtained in 85 per cent. Rasmussen (5) found that out of ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.